DE60203818D1 - Benzotriazepine als gastrin und cholecystokinin rezeptor liganden - Google Patents

Benzotriazepine als gastrin und cholecystokinin rezeptor liganden

Info

Publication number
DE60203818D1
DE60203818D1 DE60203818T DE60203818T DE60203818D1 DE 60203818 D1 DE60203818 D1 DE 60203818D1 DE 60203818 T DE60203818 T DE 60203818T DE 60203818 T DE60203818 T DE 60203818T DE 60203818 D1 DE60203818 D1 DE 60203818D1
Authority
DE
Germany
Prior art keywords
cholecystokinine
benzotriazepine
liganden
gastrin
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60203818T
Other languages
English (en)
Other versions
DE60203818T2 (de
Inventor
Iain Mair Mcdonald
Ildiko Maria Buck
Elaine Anne Harper
Ian Duncan Linney
Michael John Pether
Katherine Isobel Mary Steel
Carol Austin
David John Dunstone
Sarkis Barret Kalindjian
Caroline Minli Rachel Low
John Spencer
Paul Trevor Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
James Black Foundation Ltd
Original Assignee
James Black Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0127262A external-priority patent/GB0127262D0/en
Priority claimed from GB0219051A external-priority patent/GB0219051D0/en
Application filed by James Black Foundation Ltd filed Critical James Black Foundation Ltd
Publication of DE60203818D1 publication Critical patent/DE60203818D1/de
Application granted granted Critical
Publication of DE60203818T2 publication Critical patent/DE60203818T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D255/00Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60203818T 2001-11-13 2002-11-12 Benzotriazepine als gastrin und cholecystokinin rezeptor liganden Expired - Fee Related DE60203818T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0127262 2001-11-13
GB0127262A GB0127262D0 (en) 2001-11-13 2001-11-13 Gastrin and cholecystokinin receptor ligands (VI)
GB0219051A GB0219051D0 (en) 2002-08-15 2002-08-15 Gastrin and cholecystokinin receptor ligands (V1-2)
GB0219051 2002-08-15
PCT/GB2002/005121 WO2003041714A1 (en) 2001-11-13 2002-11-12 Benzotriazepines as gastrin and cholecystokinin receptor ligands

Publications (2)

Publication Number Publication Date
DE60203818D1 true DE60203818D1 (de) 2005-05-25
DE60203818T2 DE60203818T2 (de) 2006-01-26

Family

ID=26246762

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60203818T Expired - Fee Related DE60203818T2 (de) 2001-11-13 2002-11-12 Benzotriazepine als gastrin und cholecystokinin rezeptor liganden

Country Status (20)

Country Link
US (1) US20060003993A1 (de)
EP (1) EP1443934B1 (de)
JP (1) JP2005513013A (de)
KR (1) KR20050044852A (de)
CN (1) CN100348196C (de)
AR (1) AR037359A1 (de)
AT (1) ATE293449T1 (de)
BR (1) BR0213317A (de)
CA (1) CA2466955A1 (de)
DE (1) DE60203818T2 (de)
ES (1) ES2240815T3 (de)
HU (1) HUP0402068A3 (de)
IL (1) IL161330A0 (de)
MX (1) MXPA04003544A (de)
NO (1) NO20042452L (de)
NZ (1) NZ532213A (de)
PL (1) PL369568A1 (de)
RU (1) RU2304438C2 (de)
TW (1) TW200303205A (de)
WO (1) WO2003041714A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004101533A1 (en) * 2003-05-12 2004-11-25 Janssen Pharmaceutica, N.V. 1, 3, 4-benzotriazepin-2-one salts and their use as cck receptor ligands
US20050043359A1 (en) * 2003-08-20 2005-02-24 The Procter & Gamble Company Kit for treatment of upper gastrointestinal tract conditions
WO2005074931A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations comprising (s) -pantoprazole
GB0425196D0 (en) * 2004-11-15 2004-12-15 Black James Foundation Gastrin and cholecystokinin receptor ligands
ES2442865T3 (es) * 2005-09-16 2014-02-14 Janssen Pharmaceutica N.V. Procedimiento para la preparación de derivados de venzo[E][1,2,4]triazepina-2-ona
GB0610018D0 (en) * 2006-05-19 2006-06-28 James Black Foundation Benzotriazepinone derivatives
WO2007135417A1 (en) * 2006-05-19 2007-11-29 James Black Foundation Benzotriazepinone derivatives
US7863330B2 (en) 2006-06-14 2011-01-04 Rottapharm S.P.A. Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders
PL3071206T3 (pl) 2013-11-22 2022-01-17 CL BioSciences LLC Antagoniści gastryny (eg yf476, netazepid) do leczenia i zapobiegania osteoporozie
GB201414116D0 (en) 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives
GB201513979D0 (en) 2015-08-07 2015-09-23 Trio Medicines Ltd Synthesis of benzodiazepine derivatives
US11097031B2 (en) 2016-08-01 2021-08-24 The Procter & Gamble Company Phase-stable, sprayable freshening compositions comprising suspended particles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3176008A (en) * 1962-09-11 1965-03-30 American Home Prod 5-phenyl-benzotriazepin-2-one compounds and their production
US5091381A (en) * 1991-04-12 1992-02-25 Biomeasure, Inc. 2H-1,3,4-benzotriazepin-2-ones
AU3247593A (en) * 1991-12-20 1993-07-28 Warner-Lambert Company Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
US5378838A (en) * 1993-01-13 1995-01-03 Merck & Co., Inc. Benzodiazepine cholecystokinin antagonists

Also Published As

Publication number Publication date
WO2003041714A1 (en) 2003-05-22
BR0213317A (pt) 2004-10-13
EP1443934B1 (de) 2005-04-20
MXPA04003544A (es) 2004-07-22
CN1585643A (zh) 2005-02-23
US20060003993A1 (en) 2006-01-05
AU2002341218B2 (en) 2007-03-15
TW200303205A (en) 2003-09-01
RU2004117880A (ru) 2005-04-20
HUP0402068A2 (hu) 2005-02-28
HUP0402068A3 (en) 2005-09-28
RU2304438C2 (ru) 2007-08-20
KR20050044852A (ko) 2005-05-13
AR037359A1 (es) 2004-11-03
IL161330A0 (en) 2004-09-27
ATE293449T1 (de) 2005-05-15
CN100348196C (zh) 2007-11-14
EP1443934A1 (de) 2004-08-11
CA2466955A1 (en) 2003-05-22
NO20042452L (no) 2004-08-12
JP2005513013A (ja) 2005-05-12
NZ532213A (en) 2006-12-22
PL369568A1 (en) 2005-05-02
DE60203818T2 (de) 2006-01-26
ES2240815T3 (es) 2005-10-16

Similar Documents

Publication Publication Date Title
DE60144334D1 (de) Myostatin-antagonisten und Verwendungen davon
ATE264960T1 (de) Paneelanordnung und verbindungsmittel
DE60210134D1 (de) Befestigungsvorrichtung
ATE268776T1 (de) Benzodiazepinderivate als gaba-a- rezeptormodulatoren
DE50205649D1 (de) Befestigungsvorrichtung
DE50208596D1 (de) Befestigungsvorrichtung
DE60131802D1 (de) Fixierelement, Fixieranordnung und Bilderzeugungsgerät
DE60011190D1 (de) Gemischte Sicherungstechnologien
DE60114413D1 (de) Substituierte 1-aminoalkyl-lactame und deren verwendung als muscarinrezeptor-antagonisten
DE69816290D1 (de) Chinolin-4-carboxamidderivate als nk-2 und nk-3 rezeptor antagonisten
DE60028172D1 (de) Beleuchtungsvorrichtung
DE60039645D1 (de) Beleuchtungseinrichtung
DE60203818D1 (de) Benzotriazepine als gastrin und cholecystokinin rezeptor liganden
DE60229938D1 (de) ENTWICKLUNGSEINRICHTUNG UND BILDformungsgerät
DE60029075D1 (de) Kopiergerät und Kopierverfahren
DE50202126D1 (de) Farbmittelkombination
DE60016353D1 (de) Schmelzfixierband
GB0310865D0 (en) Gastrin and cholecystokinin receptor ligands
DE60222015D1 (de) Ccr-3-rezeptorantagonisten vii
DE60017224D1 (de) Arbeitseinheit und elektrophotographiches Gerät
ITMI992190A0 (it) Rubinetto
DE50213177D1 (de) Befestigungsvorrichtung
NO20016057L (no) Avfallssorteringsanordning
DE29907454U1 (de) Beleuchtungseinrichtung
DE60037742D1 (de) Mischungen fluoreszierender aufheller

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: WITTE, WELLER & PARTNER, 70178 STUTTGART

8339 Ceased/non-payment of the annual fee